Oral Lichen planus (OLP) is an autoimmune, chronic, mucocutaneous disease affecting skin, genital mucosa, nails, scalp and oral mucosa. Low level lasers therapy (LLLT) has come up now days as a new treatment modality for oral lichen planus without having significant adverse effects. Total twenty four (24) patients who were diagnosed with signs and symptoms of oral lichen planus and included in the study this study evaluate and compare the efficacy of low level laser therapy and topical corticosteroid (0.1% Kenacort gel) therapy in the management of OLP. In our study we have found more number of oral lichen planus patients in the age range from 20–70 years with a mean age of 40 ± 13. Whereas, a significant reduction in pain scores were found in patients treated with low level lasers than in patients treated with topical corticosteroids. Patients treated with low level laser showed a great enhancement in quality of life and resolution of symptoms as compared to corticosteroid.